Incorporating Innovative B-Cell Targeting Therapeutics into a Combined-Modality Bridging Approach Followed by Timely Consolidative Haploidentical Transplantation to Salvage a Pediatric Patient with Relapsed/Refractory Diffuse Large B-Cell LymphomaYu-Ju Chao1, Pei-Ing Lee2, Tzu-Hsien Yang3, Li-Hua Fang4, Yu-Chun Tsai5, Ming-Yuan Lee6, Yun-Hsin Wang7, Liuh-Yow Chen3, and Rong-Long Chen1*1Department of Pediatric Hematology and Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan2Department of Nuclear Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan3 Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan4Department of Pharmacy, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan5Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan6Department of Pathology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan7Department of Molecular Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan*Corresponding author: RL ChenName : Rong-Long Chen, M.D.Tel. no. : 886-2-2897-0011; Fax no. : 886-2-2896-2591E-mail : [email protected] : No. 125, Lih-Der Road, Pei-Tou District, Taipei, Taiwan, 11259Word count : Main text (excludes Title page, Abstract, Conflicts of Interest Statement, Acknowledgments, References, Tables, Figures, and Legends) 850.Number of Tables, Figures, and Supporting Information files: 2Running title : Novel Salvage of Resistant Large Cell lymphomaKeywords : Antibody-drug conjugates; chimeric antigen receptor T-cells; diffuse large B-cell lymphoma; HLA haplo-identical transplantation; childhood; peripheral blood stem cell transplantation.